Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

Hereditary Cancer in Clinical Practice
Mark HarlandSusana Puig

Abstract

Mutations in the CDKN2A and CDK4 genes predispose to melanoma. From three case-control studies of cutaneous melanoma, we estimated the prevalence and predictors of these mutations for people from regions with widely differing latitudes and melanoma incidence. Population-based cases and controls from the United Kingdom (1586 cases, 499 controls) and Australia (596 early-onset cases, 476 controls), and a hospital-based series from Spain (747 cases, 109 controls), were screened for variants in all exons of CDKN2A and the p16INK4A binding domain of CDK4. The prevalence of mutations for people with melanoma was similar across regions: 2.3%, 2.5% and 2.0% for Australia, Spain and the United Kingdom respectively. The strongest predictors of carrying a mutation were having multiple primaries (odds ratio (OR) = 5.4, 95% confidence interval (CI: 2.5, 11.6) for 2 primaries and OR = 32.4 (95% CI: 14.7, 71.2) for 3 or more compared with 1 primary only); and family history (OR = 3.8; 95% CI:1.89, 7.5) for 1 affected first- or second-degree relative and OR = 23.2 (95% CI: 11.3, 47.6) for 2 or more compared with no affected relatives). Only 1.1% of melanoma cases with neither a family history nor multiple primaries had mutations. There is a lo...Continue Reading

Associated Clinical Trials

Aug 31, 2020·Katherine Nathanson, MD

References

Nov 5, 1997·Journal of the National Cancer Institute·D C WhitemanN K Hayward
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J BlackD M Parkin
Mar 27, 1998·The New England Journal of Medicine·J MonzonN J Lassam
Oct 31, 2002·The Journal of Investigative Dermatology·Chandra G BertramJulia A Newton Bishop
Dec 18, 2002·The Journal of Investigative Dermatology·N SoufirN Basset-Seguin
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susana PuigMontserrat Milà
Jan 7, 2006·The Journal of Investigative Dermatology·Mark J EliasonSancy A Leachman
Apr 15, 2006·The Journal of Investigative Dermatology·Tania SpicaUNKNOWN MELAN-COHORT
Aug 10, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marianne BerwickUNKNOWN GEM Study Group
Aug 15, 2006·Journal of Medical Genetics·Alisa M GoldsteinUNKNOWN Melanoma Genetics Consortium (GenoMEL)
Jan 16, 2007·The Journal of Investigative Dermatology·Irene OrlowUNKNOWN GEM Study Group
Nov 21, 2007·Genes, Chromosomes & Cancer·Per HelsingPer Arne Andresen
Jan 8, 2008·Journal of Medical Genetics·A M GoldsteinK Stefansson
Apr 9, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mark HarlandUNKNOWN GenoMEL, the Melanoma Genetics Consortium
Mar 18, 2009·Biochemical Society Transactions·Claire F Taylor
Jun 16, 2009·The British Journal of Dermatology·A Larre BorgesS Puig
Jul 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Juliette A Randerson-MoorJulia A Newton Bishop
Aug 4, 2009·Lancet·John F ThompsonRichard F Kefford
Sep 16, 2009·Journal of the American Academy of Dermatology·Sancy A LeachmanHensin Tsao
Apr 5, 2011·Human Mutation·Peter J MillerMarc S Greenblatt
Aug 2, 2011·The British Journal of Dermatology·V NikolaouH Tsao

❮ Previous
Next ❯

Citations

Apr 10, 2016·Journal of the National Cancer Institute·Shumei KatoRazelle Kurzrock
Aug 17, 2018·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Anne E CustMarianne Berwick
Apr 18, 2018·Journal of Medical Genetics·Thomas P PotjerUNKNOWN Dutch Working Group for Clinical Oncogenetics
Feb 19, 2019·Dermatology Practical & Conceptual·Mariarita RossiMaria Concetta Fargnoli
Jan 21, 2019·Occupational and Environmental Medicine·Fraser Brims
Oct 7, 2018·Journal of Medical Genetics·Hildur HelgadottirGöran Jönsson
Nov 12, 2018·Occupational and Environmental Medicine·Laura S WelchKnut Ringen
Jul 16, 2020·Journal of the Endocrine Society·Kevin C MillerKeith C Bible
Sep 13, 2018·Cancer·Alisa M GoldsteinMargaret A Tucker
Aug 7, 2019·BMC Cancer·Milena CasulaUNKNOWN Italian Melanoma Intergroup (IMI)
Oct 27, 2020·BioMed Research International·Jose D Tovar-ParraLeonardo Pulido
Mar 27, 2021·Hereditary Cancer in Clinical Practice·Sock Hoai ChanJoanne Ngeow
Jun 20, 2021·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Satyamaanasa PolubothuVeronica A Kinsler

❮ Previous
Next ❯

Software Mentioned

SAS
Polyphen

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.